Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$94,847,869
+$2,899,544 QoQ
Shares Held
3,938,865
+20.3% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#102
of 2,826 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $3,273,366,479 across 12 Drug Manufacturers - General names. PFE ranks #8 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,068,333 | $1,033,234,532 | |
| 2 | LLY |
ELI LILLY & Co
|
580,460 | $696,221,195 | |
| 3 | ABBV |
AbbVie Inc.
|
1,707,786 | $429,747,269 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,373,431 | $304,985,883 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,033,130 | $256,865,644 | |
| 6 | AZN |
Astrazeneca PLC
|
1,328,471 | $251,904,671 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,064,284 | $118,944,044 | |
| 8 | PFE |
Pfizer Inc
This page
|
3,938,865 | $94,847,869 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $94,847,869 | 3,938,865 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $91,948,325 | 3,274,513 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $77,410,987 | 3,108,875 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $79,157,289 | 3,106,644 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $34,296,473 | 1,414,871 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $21,398,692 | 844,463 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $17,242,191 | 649,913 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $21,603,362 | 746,488 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $24,933,481 | 891,118 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $49,525,314 | 1,784,696 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $49,429,579 | 1,716,901 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $40,746,757 | 1,228,422 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $56,639,348 | 1,544,148 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $56,341,658 | 1,380,923 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $74,148,686 | 1,447,086 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $69,238,691 | 1,582,237 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $81,939,753 | 1,562,841 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $69,238,129 | 1,337,418 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $74,257,205 | 1,257,531 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $58,955,613 | 1,370,742 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $49,560,151 | 1,265,581 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $53,324,473 | 1,471,832 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $35,239,538 | 957,336 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $33,981,046 | 925,915 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $36,181,737 | 1,106,474 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $39,949,608 | 1,223,948 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||